Fig. 3.

Documented symptomatic hypoglycemia during the 30-week treatment period (30-week completers; modified intent-to-treat population). ^aDocumented symptomatic hypoglycemia includes events with typical symptoms of hypoglycemia and a measured plasma glucose concentration of ≤ 70 mg/dL (≤ 3.9 mmol/L). p-y Patient-year